{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70377-092",
      "generic_name": "Everolimus",
      "labeler_name": "Biocon Pharma Inc.",
      "brand_name": "Everolimus",
      "active_ingredients": [
        {
          "name": "EVEROLIMUS",
          "strength": "5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70377-092-11",
          "description": "28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-092-11)",
          "marketing_start_date": "20260114",
          "sample": false
        },
        {
          "package_ndc": "70377-092-23",
          "description": "4 BLISTER PACK in 1 CARTON (70377-092-23)  / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK",
          "marketing_start_date": "20260114",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Biocon Pharma Inc."
        ],
        "rxcui": [
          "1308428",
          "1308430",
          "1308432"
        ],
        "spl_set_id": [
          "5b809dfe-c076-07c5-207e-178c3f0d32d3"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0370377092114",
          "0370377090110",
          "0370377091117",
          "0370377091230",
          "0370377090233"
        ],
        "nui": [
          "N0000175605",
          "N0000175076",
          "N0000182141",
          "N0000182137",
          "N0000175625",
          "N0000175624",
          "N0000175550"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]",
          "mTOR Inhibitor Immunosuppressant [EPC]"
        ],
        "pharm_class_moa": [
          "Protein Kinase Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "Cytochrome P450 2D6 Inhibitors [MoA]",
          "mTOR Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Immunologic Activity [PE]"
        ],
        "unii": [
          "9HW64Q8G6G"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FOR SUSPENSION",
      "spl_id": "7f7c486a-aefb-4798-aa9f-365799886a72",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260114",
      "product_id": "70377-092_7f7c486a-aefb-4798-aa9f-365799886a72",
      "application_number": "ANDA217216",
      "brand_name_base": "Everolimus",
      "pharm_class": [
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Decreased Immunologic Activity [PE]",
        "Kinase Inhibitor [EPC]",
        "Protein Kinase Inhibitors [MoA]",
        "mTOR Inhibitor Immunosuppressant [EPC]",
        "mTOR Inhibitors [MoA]"
      ]
    }
  ]
}